Archives

Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development

B Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies SUZHOU, China and BOSTON, April 10, 2026 /PRNewswire/ — Vivatides Therapeutics, a global… Login to continue reading Login…

Read MoreVivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development

Erayak Announces Strategic Evolution into U.S.-Centric Energy Solutions Leader; Unveils Tri-Fuel & UPS Innovations Following 2026 NHS Success

B From OEM Roots to a Vertically Integrated North American Powerhouse, Nexora Spearheads Erayak’s Mission to Power the AI and Smart Home Revolution NEW YORK,… Login to continue reading Login…

Read MoreErayak Announces Strategic Evolution into U.S.-Centric Energy Solutions Leader; Unveils Tri-Fuel & UPS Innovations Following 2026 NHS Success